MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
Greenlane Holdings Accounts Receivables 2011-2026 | GNLN
Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.Examples of accounts receivable
- Customers have not paid invoices for delivered products
- An advance has been paid to a supplier, but goods have not yet been received
- Employees have not reported on accountable amounts
- The government must refund tax overpayments
- Outstanding loans issued
- Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment. - Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages. - Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)
Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)
If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.
Annual Accounts Receivables Greenlane Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.47 M | 14.7 M | 6.33 M | 8.09 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.7 M | 6.33 M | 8.89 M |
Quarterly Accounts Receivables Greenlane Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.14 M | 3.8 M | 4.9 M | 2.31 M | 1.92 M | - | 1.92 M | 3.09 M | 7.86 M | 6.47 M | 11.8 M | 15.6 M | 19.9 M | 14.7 M | 15.2 M | 5.65 M | 5.52 M | 6.33 M | 6.33 M | 6.33 M | 6.33 M | 8.09 M | 8.09 M | 8.09 M | 8.09 M | 8.22 M | 8.22 M | 8.22 M | 8.22 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 19.9 M | 1.92 M | 7.69 M |
Accounts Receivables of other stocks in the Pharmaceutical retailers industry
| Issuer | Accounts Receivables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BOQI International Medical
BIMI
|
3.21 M | - | 6.33 % | $ 5.86 M |  China |
 |
Trxade Group
MEDS
|
822 K | - | 4.55 % | $ 5.8 M |  USA |
 |
PetMed Express
PETS
|
2.32 M | $ 3.2 | -1.54 % | $ 65.9 M | USA |
 |
111
YI
|
163 M | $ 2.53 | -3.8 % | $ 435 M | China |
 |
LifeMD
LFMD
|
5.28 M | $ 3.41 | -2.29 % | $ 116 M | USA |
 |
Rite Aid Corporation
RAD
|
1.15 B | - | - | $ 35.5 M | USA |
 |
Walgreens Boots Alliance
WBA
|
5.85 B | - | - | $ 10.3 B | USA |